← Open Payments lookup

RIGARDY MUNOZ: Open Payments

NPI 1427092972 · WILMINGTON, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$847 in 32 payments from 13 companies in 2025. Trend: 2023 $846 · 2024 $524 · 2025 $847

Food & beverage: $847
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$217
Supernus Pharmaceuticals, Inc.2$129
Bausch Health US, LLC4$85
Teva Pharmaceuticals USA, Inc.4$83
Neurocrine BioSciences, Inc.3$76
Otsuka America Pharmaceutical, Inc.3$61
Alkermes, Inc.3$52
E.R. Squibb & Sons, L.L.C.2$41
Takeda Pharmaceuticals U.S.A., Inc.2$28
Lundbeck LLC1$24

Products named: CAPLYTA, Qelbree, APLENZIN, REXULTI, UZEDY, INGREZZA, ARISTADA, COBENFY.

Industry payments across NC — which companies pay providers there.